Scott Gottlieb, MD
Dermatology · Exton, PANPI 1285693887
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,847,360 of the $2,099,480 with a category attached, or 88.0%. It is spread thinly across 25 manufacturers, the largest accounting for just 23.2%. Among dermatology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,898 payments — averaging $1106.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$487K
- Sun Pharmaceutical Industries Inc.$414K
- Johnson & Johnson$320K
- Janssen Scientific Affairs, LLC$271K
- E.r. Squibb & Sons, L.L.C.$260K
- UCB, Inc.$122K
- plus $225K from 19 others
Across 129 payments — averaging $10,729 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$848K
- Amgen$239K
- E.r. Squibb & Sons, L.L.C.$197K
- Janssen Research & Development, LLC$86K
- Dermira, Inc.$7K
- Merck$6K
- plus $1K from 2 others
What the payments were for
- Consulting fees$72,8133%
- Speaking & faculty fees$1,847,36088%
- Grants$870%
- Travel & lodging$144,0657%
- Food & beverage$34,8552%
- Education$3000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 574 | $487,221 |
| Sun Pharmaceutical Industries Inc. | 285 | $413,904 |
| Johnson & Johnson | 298 | $320,145 |
| Janssen Scientific Affairs, LLC | 195 | $271,393 |
| E.r. Squibb & Sons, L.L.C. | 217 | $259,707 |
| UCB, Inc. | 98 | $121,863 |
| Galderma Laboratories, L.p. | 75 | $95,551 |
| AbbVie | 74 | $78,926 |
| Incyte Corporation | 35 | $32,294 |
| Novartis | 10 | $7,176 |
| Eli Lilly | 3 | $4,687 |
| Arcutis Biotherapeutics, Inc. | 9 | $4,049 |
| Boehringer Ingelheim | 1 | $2,040 |
| Pfizer | 7 | $122 |
| LEO Pharma Inc. | 1 | $105 |
| Amgen | 4 | $81 |
| Sanofi | 2 | $47 |
| Dermavant Sciences, Inc. | 3 | $47 |
| Bristol Myers Squibb | 1 | $23 |
| Medtronic | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Convatec Inc. | 1 | $21 |
| Promius Pharma LLC | 1 | $20 |
| DUSA Pharmaceuticals, Inc. | 1 | $11 |
| Organon | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,099,480 in reported general payments places this provider in the 95th percentile of 626 dermatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 13 | $48,453 |
| Clobetasol Propionate | 118 | $6,234 |
| Metronidazole | 56 | $2,655 |
| Triamcinolone Acetonide | 201 | $2,261 |
| Doxycycline Hyclate | 36 | $1,469 |
| Azelaic Acid | 19 | $1,424 |
| Hydrocortisone Valerate | 16 | $1,411 |
| Fluorouracil | 22 | $1,398 |
| Ketoconazole | 61 | $1,316 |
| Tacrolimus | 11 | $1,309 |
| Halobetasol Propionate | 25 | $1,066 |
| Hydrocortisone | 49 | $286 |
| Minocycline Hcl | 18 | $270 |
| Mupirocin | 32 | $170 |
| Selenium Sulfide | 13 | $157 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Exton
- Douglas KressWexford$2M
- Stephen HessPhiladelphia$1.7M
- Adel HaqueYardley$1M
- Joel GelfandPhiladelphia$649K
- Neil NirenPittsburgh$574K
- Victoria WerthPhiladelphia$547K
- Mark SeralyMc Murray$545K
- Laura FerrisPittsburgh$502K
- Oleg AkilovPittsburgh$409K
- Joslyn Sciacca-KirbyHershey$405K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.